
On May 3rd, Japan Tobacco Inc. (JTI) released its first quarter financial report for 2023. According to the report, JTI's revenue for the first quarter of 2023 was 665.3 billion Japanese yen (US$4.86 billion), a 14.4% increase year-over-year. Operating profit was 206.4 billion yen ($1.5 billion), a 15.7% increase, and net profit was 144.7 billion yen ($1.06 billion), a 16.6% increase.
Masamichi Terabatake, President and CEO of Japan Tobacco, has announced that the company achieved solid results in the first quarter of the year, based on its positive business momentum. The strong pricing of the tobacco business continued to drive the robust performance of the company.
According to Masamichi Terabatake, the increase in sales of heated tobacco sticks (HTS) has resulted in favorable financial results for Japan Tobacco. Following the successful launch of Ploom X in the United Kingdom, HTS has also been introduced in Italy and Lithuania in April, and will continue to be rolled out in Portugal in mid-May.
According to previous reports, on April 15th, Japan Tobacco announced its plans to invest 300 billion yen (approximately 2.25 billion USD) over the next three years in promoting its heat-not-burn product, Ploom X. Of this investment, 200 billion yen (approximately 1.5 billion USD) will be allocated to markets outside of Japan. The company aims to launch Ploom X in over 10 countries this year and expand to at least 20 countries by the end of 2024.
Read more related articles:
Japan Tobacco is planning to increase its investment in Ploom X and aims to expand the product's reach to at least 20 countries by the end of 2024.
Japan Tobacco Inc. has reported a 1.3% decrease in sales due to a lack of new tobacco channels in South Korea.
In 2022, the net profit of Japan Tobacco's Russian subsidiary increased by more than 1.5 times.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.









